SCHEMBL6136580

SCHEMBL6136580

CCCCCCCCCCCCCCCCCc1cc2ccccc2oc1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.59
MAOA P21397 3/20 0.59
MMP2 P08253 1/20 0.55
MMP9 P14780 1/20 0.55
ADAM17 P78536 1/20 0.55
MAPT P10636 3/20 0.54
LMNA P02545 2/20 0.50
KDM4E B2RXH2 4/20 0.49
MEN1 O00255 3/20 0.49
HTT P42858 3/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HPGD P15428 3/20 0.49
GAA P10253 2/20 0.49
APAF1 O14727 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
POLB P06746 1/20 0.49
STAT6 P42226 1/20 0.49
HIF1A Q16665 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21385208 1.00 MAOB (0.59) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL28535264 1.00 MAOB (0.59) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL45450 0.98 MAOB (0.61) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL3506842 0.94 MAOB (0.62) MAOBMAOAMMP2MMP9ADAM17
Thiophene SCHEMBL27776643 0.90 MAOB (0.53) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL11092927 0.87 MAOB (0.66) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL6136579 0.87 MAOB (0.47) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL31506362 0.85 MMP2 (0.58) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL293818 0.85 MMP2 (0.55) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL27625488 0.84 MMP2 (0.67) MAOBMAOAMMP2MMP9ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0951557-A4 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS CUBIST PHARM INC (US) 2005-02-09 EP disclosed
EP-1159432-A4 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS TERRAGEN DISCOVERY INC (US) 2003-04-16 EP disclosed
EP-0822990-A4 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS CHROMAXOME CORP (US) 2002-07-03 EP disclosed
EP-1159432-A1 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS Terragen Discovery Inc. (US) 2001-12-05 EP disclosed
US-6242211-B1 GENE EXPRESSION LIBRARY; FOR USE AS TOOL IN THE DETECTION AND ISOLATION OF THERAPEUTIC COMPOUNDS TERRAGEN DISCOVERY, INC. (CA) 2001-06-05 US disclosed
WO-2000052180-A1 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS TERRAGEN DISCOVERY INC. (US) 2000-09-08 WO disclosed
EP-0951557-A1 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS Chromaxome Corp. (US) 1999-10-27 EP disclosed
WO-1998017811-A1 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS CHROMAXOME CORPORATION (US) 1998-04-30 WO disclosed
EP-0822990-A1 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS Chromaxome Corp. (US) 1998-02-11 EP disclosed
WO-1996034112-A1 METHODS FOR GENERATING AND SCREENING NOVEL METABOLIC PATHWAYS CHROMAXOME CORP. (US) 1996-10-31 WO disclosed